The Discounted Cash Flow (DCF) valuation of Aridis Pharmaceuticals Inc (ARDS) is (15,343,027.19) USD. With the latest stock price at 0.31 USD, the upside of Aridis Pharmaceuticals Inc based on DCF is -4947767656.7%.
Based on the latest price of 0.31 USD and our DCF valuation, Aridis Pharmaceuticals Inc (ARDS) is a sell. selling ARDS stocks now will result in a potential gain of 4947767656.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.3% - 4.7% | 4.5% |
| Long-term Growth Rate | 3.0% - 4.1% | 3.5% |
| Fair Price | (58,555,315.14) - (8,905,453.61) | (15,343,027.19) |
| Upside | -18882720235.2% - -2871800682.1% | -4947767656.7% |